Industry NewsRandox Laboratories and Biosytems International Announce Completion of Clinical Trial and Licensing for QuantiPlasma™ Antibodies for Early Lung Cancer Diagnostics
Product NewsRandox H-FABP, the Biomarker of Myocardial Ischemia that’s Detectable as early as 30 Minutes from Chest Pain Onset
Industry NewsRANDOX Invests £15 Million in R&D ‘Roadmap’ to Target the International Personalised Medicine Market
Industry News3 Million People in England Could Have Been Spared Chronic Kidney Disease – Health Watchdog Calls for Changes to Testing
